International Tech Times
SEE OTHER BRANDS

Your science and technology news reporter

International Tech Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on International Tech Times.

Press releases published on April 25, 2025

North American Construction Group Ltd. Announces Pricing of Private Placement Offering of $225 Million Senior Unsecured Notes

North American Construction Group Ltd. Announces Pricing of Private Placement Offering of $225 Million Senior Unsecured Notes

ACHESON, Alberta, April 25, 2025 (GLOBE NEWSWIRE) -- North American Construction Group Ltd. (“NACG”) (TSX: NOA / NYSE: NOA) announced today that it has entered into an underwriting agreement to sell, pursuant to a private placement offering (the “Offering …

Greif Honored as Stevie® Award Winner in 2025 American Business Awards®

Greif Honored as Stevie® Award Winner in 2025 American Business Awards®

DELAWARE, Ohio, April 25, 2025 (GLOBE NEWSWIRE) -- Greif, Inc. (NYSE: GEF, GEF.B), a global leader in industrial packaging products and services, announced today it has been recognized with a Gold and Silver Stevie® Award in the Management - Manufacturing …

VYNE Therapeutics Provides Update on VYN202 Program

VYNE Therapeutics Provides Update on VYN202 Program

BRIDGEWATER, N.J., April 25, 2025 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) verbally informed the Company that it placed a clinical hold on the …

Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711

Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711

SAN DIEGO, April 25, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced that in connection with the …

Silicon Motion Confirms Quarterly Dividend

Silicon Motion Confirms Quarterly Dividend

TAIPEI, Taiwan and MILPITAS, Calif., April 25, 2025 (GLOBE NEWSWIRE) -- Silicon Motion Technology Corporation (NasdaqGS: SIMO)(“Silicon Motion” or the “Company”), a global leader in designing and marketing NAND flash controllers for solid state storage …

Genius Group to Release Full Year 2024 Results and Host Investor Webcast on April 30, 2025

Genius Group to Release Full Year 2024 Results and Host Investor Webcast on April 30, 2025

SINGAPORE, April 25, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, will announce full year 2024 financial results on Wednesday, April 30, 2025, …

Brain Computer Interface Market Size Worth USD 12.40 Bn by 2034, Expands Rapidly as Healthcare and Gaming Sectors Embrace Neurotechnology

Brain Computer Interface Market Size Worth USD 12.40 Bn by 2034, Expands Rapidly as Healthcare and Gaming Sectors Embrace Neurotechnology

Ottawa, April 25, 2025 (GLOBE NEWSWIRE) -- The brain computer interface market is expected to expand at a double-digit CAGR of 17.35% from 2025 to 2034. The market projected the valuation at USD 2.62 billion in 2024 and is likely to be valued at USD 12.40 …

SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders

SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders

TEL AVIV, Israel, April 25, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, …

Clearmind Medicine Files International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders

Clearmind Medicine Files International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders

Vancouver, Canada, April 25, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …

Spryker von RetailTech Breakthrough als „E-Commerce-Lösung des Jahres 2025“ ausgezeichnet

Spryker von RetailTech Breakthrough als „E-Commerce-Lösung des Jahres 2025“ ausgezeichnet

BERLIN und NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Spyker, die führende Composable-Commerce-Plattform für anspruchsvolle Anwendungsfälle im B2B-Commerce, Enterprise Marketplaces und IoT Commerce, hat heute bekanntgegeben, dass das Unternehmen im …

Spryker est nommée « Solution e-commerce de l’année » 2025 par RetailTech Breakthrough

Spryker est nommée « Solution e-commerce de l’année » 2025 par RetailTech Breakthrough

BERLIN et NEW YORK, 25 avr. 2025 (GLOBE NEWSWIRE) -- Spryker, la principale plateforme de commerce modulaire pour les cas d’utilisation sophistiqués autour du B2B Commerce, des Enterprise Marketplaces et de l’IoT Commerce, a annoncé aujourd’hui avoir reçu …

Bitcoin has skyrocketed recently – SIX MINING provides you with stable passive income

Bitcoin has skyrocketed recently – SIX MINING provides you with stable passive income

London, UK, April 25, 2025 (GLOBE NEWSWIRE) -- London, UK Apr 24, 2025 (Copper) Affected by the latest trade policy of US President Donald Trump, the global market is volatile, but cryptocurrencies are rising against the trend - Bitcoin has broken through …

Junshi Biosciences Announces the sNDA Approval of Toripalimab for the 1st-line Treatment of Melanoma

Junshi Biosciences Announces the sNDA Approval of Toripalimab for the 1st-line Treatment of Melanoma

SHANGHAI, April 25, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel …

Flush Factor Plus Reviews (Complaints & Side Effects) Investigative Report on Its Effectiveness for Joint Health!

Flush Factor Plus Reviews (Complaints & Side Effects) Investigative Report on Its Effectiveness for Joint Health!

MIAMI, April 25, 2025 (GLOBE NEWSWIRE) -- Flush Factor Plus is a natural dietary supplement that claims to support fluid retention and promote joint mobility and flexibility. Knee pain and joint issues due to improper fluid circulation are common issues …

Best Over the Counter (OTC) Appetite Suppressant Pills 2025: Strongest Natural Hunger Control Suppressants from PhenQ

Best Over the Counter (OTC) Appetite Suppressant Pills 2025: Strongest Natural Hunger Control Suppressants from PhenQ

New York City, April 25, 2025 (GLOBE NEWSWIRE) -- Struggling with constant cravings or late-night snacking? You're not alone. In 2025, appetite control has become one of the most critical challenges in any successful weight loss journey. That’s why …

Polyrizon Reports Successful Safety Study of a Formulation of PL-14 Allergy Blocker in Human Nasal Tissue Model

Polyrizon Reports Successful Safety Study of a Formulation of PL-14 Allergy Blocker in Human Nasal Tissue Model

Raanana, Israel, April 25, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced today the successful …

Y-mAbs Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating CD38-SADA Pre-targeted Radioimmunotherapy in Relapsed/Refractory Non-Hodgkin Lymphoma

Y-mAbs Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating CD38-SADA Pre-targeted Radioimmunotherapy in Relapsed/Refractory Non-Hodgkin Lymphoma

NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody-based …

Echo Launches Real Unique Tokenomics with Real Yield in USDC

Echo Launches Real Unique Tokenomics with Real Yield in USDC

Douglas, Isle of Man, April 25, 2025 (GLOBE NEWSWIRE) -- Echo is about to launch a digital asset that intersects trading income with blockchain openness. The echo token, set to go live on May 15th, has a long list of promises for Web3 fans.  The token’s …

BPGbio Highlights Groundbreaking Data on BPM31510 for Mitochondrial Diseases at the Inaugural Mitochondrial Transplantation and Next Generation Therapeutics Conference

BPGbio Highlights Groundbreaking Data on BPM31510 for Mitochondrial Diseases at the Inaugural Mitochondrial Transplantation and Next Generation Therapeutics Conference

BOSTON, April 25, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a leading biology-first, AI-powered clinical-stage biopharma company focused on mitochondrial biology and protein homeostasis, today announced a poster presentation at the inaugural Mitochondrial …

VEON Files its 2024 Annual Report on Form 20-F

VEON Files its 2024 Annual Report on Form 20-F

Dubai, April 25, 2025: VEON Ltd. (Nasdaq: VEON), a global digital operator (‘VEON’ or the ‘Company’), today announces that it has filed its Annual Report on Form 20-F for the year ended December 31, 2024 (the "2024 20-F") with the U.S. Securities and …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service